from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2301/cut2

LFCtreatmentdescriptionclass of inhibitor

1.031

Amikacinug/mL Amikacintranslation

1.719

Cap5-10ug/mL Capreomycintranslation

1.698

Rox10-50 ug/mL Roxithromycintranslation

1.350

SM2-5 ug/mL Streptomycintranslation

0.738

Tet5-10 ug/mL Tetracyclinetranslation

-0.227

Rif0.2-5ug/mL Rifampicintranscription

-0.005

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.565

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.584

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.969

CPZ10-50 ug/mL Chlorpromazinerespiration

0.260

Clofazimine10-13 ug/mL Clofaziminerespiration

0.465

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.976

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.752

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.852

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.602

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.450

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.501

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.485

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.477

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.809

KCN5-20 ug/mL Potassium cyaniderespiration

-0.444

NaN30.2-2 mM Sodium aziderespiration

1.171

Nigericin50 uM Nigericinrespiration

-0.632

TRC10-150 ug/mL Triclosanrespiration

-1.039

TRZ10-25 ug/mL Thioridazinerespiration

-1.439

Valinomycin0.5-10 uM Valinomycinrespiration

0.619

ZnSO42 mM ZnSO4respiration

-0.685

menadione6-10 ug/mL Menadionerespiration

0.449

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.622

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.770

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.745

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.137

NRP_1Non-replicating persistence stage 1dosRassociated

0.619

Amp0.2mg/mL AmpicillincellWall

0.263

Cephalexin20-100 ug/mL CephalexincellWall

0.323

Cerulenin0.32-5 ug/mL CerulenincellWall

0.850

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.564

EMB10-20 ug/mL EthambutolcellWall

0.420

Eta12-40 ug/mL EthionamidecellWall

0.297

INH0.2-0.4 ug/mL IsoniazidcellWall

0.284

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.302

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.052

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.786

BZA0.12 mg/mL BenzamidearomaticAmides

-0.859

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.850

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.442

H2O24 mM hydrogen peroxideDNAdamaging

0.487

Levo10 ug/mL LevofloxacinDNAdamaging

0.376

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.457

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.507

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.463

UVUV-irradiationDNAdamaging

-0.355

ARP41-4 ug/mL Antitubercular compound ARP4?

0.634

Antimycin12.5-50 ug/mL Antimycin A?

0.551

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.116

PA_110-50 ug/mL Antitubercular compound PA-1?

0.173

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.516

PA8240.2-2 ug/mL PA-824?

-1.455

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.355

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.471

Verapamil50 uM Verapamil?

1.493

mercaptoethanol2 mM 2-Mercaptoethanol?

0.683

methoxatin10-20 ug/mL Methoxatin?